LIBERATORE, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 924
AS - Asia 569
EU - Europa 368
SA - Sud America 101
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 19
OC - Oceania 1
Totale 2.077
Nazione #
US - Stati Uniti d'America 853
SG - Singapore 221
IT - Italia 164
CN - Cina 131
BR - Brasile 81
VN - Vietnam 75
BD - Bangladesh 61
RU - Federazione Russa 60
HK - Hong Kong 25
CA - Canada 24
DE - Germania 23
GB - Regno Unito 22
LT - Lituania 20
FI - Finlandia 18
MX - Messico 14
AT - Austria 12
IN - India 11
NL - Olanda 10
PL - Polonia 9
CR - Costa Rica 8
FR - Francia 8
TR - Turchia 7
AR - Argentina 6
ES - Italia 6
JP - Giappone 6
SC - Seychelles 6
GT - Guatemala 5
PK - Pakistan 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BE - Belgio 4
EC - Ecuador 4
SV - El Salvador 4
UZ - Uzbekistan 4
CL - Cile 3
KR - Corea 3
NI - Nicaragua 3
SE - Svezia 3
VE - Venezuela 3
CO - Colombia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
ID - Indonesia 2
IE - Irlanda 2
IL - Israele 2
JM - Giamaica 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.982
Città #
Singapore 165
San Jose 148
Dallas 82
Ashburn 66
Council Bluffs 64
Los Angeles 31
Pescara 31
Beijing 30
Ho Chi Minh City 26
Hong Kong 25
North Bergen 23
Santa Clara 22
New York 21
Phoenix 20
Hanoi 19
Buffalo 16
Vilnius 15
Milan 14
Columbus 13
Orem 13
Rome 11
São Paulo 11
Lappeenranta 10
Shenzhen 10
Hefei 9
Mexico City 9
Helsinki 8
Nuremberg 8
The Dalles 8
Tongling 8
Chicago 7
Frankfurt am Main 7
Warsaw 7
Atlanta 6
Chennai 6
Montreal 6
Naples 6
Redondo Beach 6
Bologna 5
Brooklyn 5
Guatemala City 5
Houston 5
Manchester 5
Moscow 5
San José 5
Vienna 5
Ankara 4
Denver 4
Haiphong 4
Lauterbourg 4
San Salvador 4
Seattle 4
Tokyo 4
Amsterdam 3
Brasília 3
Charlotte 3
Cleveland 3
Da Nang 3
Florence 3
Francavilla al Mare 3
Fresno 3
Hải Dương 3
Jeddah 3
Johannesburg 3
Kansas City 3
League City 3
London 3
Mumbai 3
Oklahoma City 3
Querétaro 3
Quito 3
San Francisco 3
Seoul 3
Tashkent 3
Toronto 3
Turin 3
Washington 3
Bari 2
Belo Horizonte 2
Boston 2
Buenos Aires 2
Caracas 2
Cartago 2
Caxias do Sul 2
Cepagatti 2
Charleston 2
Chieti 2
Curitiba 2
Dublin 2
Ghent 2
Greenville 2
Honolulu 2
Hove 2
Jacksonville 2
João Pessoa 2
Kingston 2
Lahore 2
Las Vegas 2
Louisville 2
Lumberton 2
Totale 1.173
Nome #
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 153
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts 123
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 123
Long-Term Survival with Multiple Myeloma: An Italian Experience 121
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 111
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 107
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB 106
Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab 104
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 96
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 94
Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation 87
Higher cyclophosphamide dose grants optimal stem-cell collection after daratumumab-based induction in multiple myeloma 86
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 84
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 80
Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia 77
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 62
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 59
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice? 57
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control 52
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 47
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 44
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 43
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations 27
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone 23
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 21
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy 16
Toward the implementation of a flow cytometry core facility for diagnostics: minimal residual disease analysis in multiple myeloma 13
Real-life venous thromboembolism risk scores in multiple myeloma receiving daratumumab, lenalidomide, and dexamethasone 13
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape 10
REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials 10
Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series 10
Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study 9
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application 9
Totale 2.077
Categoria #
all - tutte 7.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 1 0 0 3 0 0 6 7 7 1 1 3
2024/2025334 8 23 20 9 20 50 42 22 30 24 28 58
2025/20261.221 53 48 123 157 118 58 165 87 113 115 119 65
2026/2027493 38 64 82 175 134 0 0 0 0 0 0 0
Totale 2.077